1. Home
  2. STEX vs TENX Comparison

STEX vs TENX Comparison

Compare STEX & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Streamex Corp.

STEX

Streamex Corp.

N/A

Current Price

$0.79

Market Cap

88.2M

Sector

N/A

ML Signal

N/A

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$2.18

Market Cap

71.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STEX
TENX
Founded
2009
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.2M
71.1M
IPO Year
2013
2001

Fundamental Metrics

Financial Performance
Metric
STEX
TENX
Price
$0.79
$2.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$9.00
$29.67
AVG Volume (30 Days)
880.2K
9.0M
Earning Date
05-17-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,044.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$1.31
52 Week High
$7.44
$19.40

Technical Indicators

Market Signals
Indicator
STEX
TENX
Relative Strength Index (RSI) 51.35 23.89
Support Level $0.81 $1.31
Resistance Level $1.07 $14.15
Average True Range (ATR) 0.09 0.20
MACD 0.00 0.17
Stochastic Oscillator 37.06 73.98

Price Performance

Historical Comparison
STEX
TENX

About STEX Streamex Corp.

Streamex Corp is a vertically integrated technology and infrastructure company. The Company is a technology company with two principal lines of business: (i) Tokenized Asset Finance, focused on digital asset and real-world asset tokenization via Streamex Exchange platform, and (ii) Biomedical Technology, focused on signal processing solutions in electrophysiology. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: